CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
U2bio Co Ltd Company Snapshot
U2bio Co Ltd operates in the Health and allied services sector. In addition to historical fundamental analyses, the complete report available to purchase compares U2bio Co Ltd with three other health care providers in Asia: Green Cross Lab Cell Corp (2019 sales of 57.90 billion Korean Won [US$51.30 million] of which 75% was Clinical Laboratory Services), Cordlife Group Limited of SINGAPORE (61.58 million Singapore Dollars [US$45.35 million] of which 97% was Banking), and Asiamedic Limited which is also based in SINGAPORE (18.99 million Singapore Dollars [US$13.98 million] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
U2bio Co Ltd
  Stock Performance Chart for U2bio Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 9,670.00
(Figures in Korean Won )
1 Week -3.1%   13 Weeks -3.3%  
4 Weeks -10.9%   52 Weeks -5.7%  
 
U2bio Co Ltd Key Data:
  Ticker: 221800 Country: Korea (South)
  Exchanges: SEO Major Industry: Health Care Equipment & Services
    Sub Industry: Health & Allied Services
  2019 Sales 18,672,792,021
(Year Ending Jan 2020).
Employees: 68
  Currency: Korean Won Market Cap: 18,377,931,700
  Fiscal Yr Ends: December Shares Outstanding: 1,900,510
  Share Type: Ordinary Closely Held Shares: 1,065,754
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.